Devyn Taylor Coskey

521 total citations
13 papers, 233 citations indexed

About

Devyn Taylor Coskey is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Devyn Taylor Coskey has authored 13 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Devyn Taylor Coskey's work include Renal cell carcinoma treatment (12 papers), Renal and related cancers (9 papers) and Cancer Genomics and Diagnostics (8 papers). Devyn Taylor Coskey is often cited by papers focused on Renal cell carcinoma treatment (12 papers), Renal and related cancers (9 papers) and Cancer Genomics and Diagnostics (8 papers). Devyn Taylor Coskey collaborates with scholars based in United States. Devyn Taylor Coskey's co-authors include Chung‐Han Lee, Robert J. Motzer, Darren R. Feldman, Sujata Patil, Martin H. Voss, Ying‐Bei Chen, James J. Hsieh, Maria I. Carlo, Joshua Chaim and A. Ari Hakimi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and European Urology.

In The Last Decade

Devyn Taylor Coskey

12 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Devyn Taylor Coskey United States	7	197	154	110	55	31	13	233
Huibiao Zhang China	8	172 0.9×	113 0.7×	103 0.9×	66 1.2×	33 1.1×	16	297
Zixin Guo China	9	129 0.7×	111 0.7×	99 0.9×	59 1.1×	35 1.1×	19	220
Guannan Kang China	6	164 0.8×	70 0.5×	183 1.7×	80 1.5×	21 0.7×	11	275
Guowu Wu China	6	129 0.7×	157 1.0×	107 1.0×	101 1.8×	20 0.6×	14	271
Anja Lisa Riediger Germany	6	126 0.6×	125 0.8×	215 2.0×	84 1.5×	23 0.7×	9	259
L Morrissey United States	3	130 0.7×	121 0.8×	49 0.4×	113 2.1×	22 0.7×	4	248
Yau H. Yu Hong Kong	2	277 1.4×	104 0.7×	66 0.6×	164 3.0×	79 2.5×	2	331
David Boucher United States	5	278 1.4×	60 0.4×	199 1.8×	149 2.7×	28 0.9×	7	334
Shrinidhi Nathany India	7	132 0.7×	73 0.5×	56 0.5×	88 1.6×	13 0.4×	53	196
Hongcheng Liu China	9	110 0.6×	121 0.8×	69 0.6×	51 0.9×	31 1.0×	15	243

Countries citing papers authored by Devyn Taylor Coskey

Since Specialization

Citations

This map shows the geographic impact of Devyn Taylor Coskey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devyn Taylor Coskey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devyn Taylor Coskey more than expected).

Fields of papers citing papers by Devyn Taylor Coskey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devyn Taylor Coskey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devyn Taylor Coskey. The network helps show where Devyn Taylor Coskey may publish in the future.

Co-authorship network of co-authors of Devyn Taylor Coskey

This figure shows the co-authorship network connecting the top 25 collaborators of Devyn Taylor Coskey. A scholar is included among the top collaborators of Devyn Taylor Coskey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devyn Taylor Coskey. Devyn Taylor Coskey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Coskey, Devyn Taylor, et al.. (2024). A review of complications after ureteral reconstruction. Asian journal of urology. 11(3). 348–356. 1 indexed citations

Carlo, Maria I., Kyrollis Attalla, Yousef Mazaheri, et al.. (2022). Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy. European Urology. 81(6). 570–573. 37 indexed citations

Feldman, Darren R., Yasser Ged, Chung‐Han Lee, et al.. (2020). Everolimus plus bevacizumab is an effective first‐line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial. Cancer. 126(24). 5247–5255. 27 indexed citations

Carlo, Maria I., Nabeela Khan, Ahmet Zehir, et al.. (2019). Comprehensive Genomic Analysis of Metastatic Non–Clear-Cell Renal Cell Carcinoma to Identify Therapeutic Targets. JCO Precision Oncology. 3(3). 1–18. 13 indexed citations

Feldman, Darren R., Chung‐Han Lee, Ana M. Molina, et al.. (2018). Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial.. Journal of Clinical Oncology. 36(6_suppl). 627–627. 1 indexed citations

Carlo, Maria I., Brandon J. Manley, Sujata Patil, et al.. (2017). Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma. PubMed. 1(1). 49–56. 38 indexed citations

Carlo, Maria I., Joshua Chaim, Sujata Patil, et al.. (2017). Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes. Clinical Genitourinary Cancer. 15(6). e987–e994. 37 indexed citations

Carlo, Maria I., Semanti Mukherjee, Yelena Kemel, et al.. (2017). Discovery and prevalence of cancer-susceptibility germline mutations (Mts) in patients (Pts) with advanced renal cell carcinoma (aRCC).. Journal of Clinical Oncology. 35(15_suppl). 4524–4524. 1 indexed citations

Carlo, Maria I., Ying‐Bei Chen, Joshua Chaim, et al.. (2016). Medullary renal cell carcinoma (RCC): Genomics and treatment outcomes.. Journal of Clinical Oncology. 34(15_suppl). 4556–4556. 1 indexed citations

10.

Voss, Martin H., Ana M. Molina, Ying‐Bei Chen, et al.. (2016). Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non–Clear Cell Renal Cell Carcinoma. Journal of Clinical Oncology. 34(32). 3846–3853. 68 indexed citations

11.

Lee, Chung‐Han, Andreas M. Hötker, Martin H. Voss, et al.. (2015). Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs. Clinical Genitourinary Cancer. 14(1). 56–62. 8 indexed citations

12.

Voss, Martin H., Ying‐Bei Chen, Joshua Chaim, et al.. (2015). A phase II trial of everolimus and bevacizumab in advanced non-clear cell renal cell cancer.. Journal of Clinical Oncology. 33(7_suppl). 411–411.

13.

Voss, Martin H., Ying‐Bei Chen, Joshua Chaim, et al.. (2015). A phase II trial of everolimus (E) and bevacizumab (B) in advanced non-clear cell renal cell cancer (ncRCC) to show efficacy in patients (pts) with papillary features.. Journal of Clinical Oncology. 33(15_suppl). 4522–4522. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact